CD79A and infection: Yet, future experiments are also required to confirm the presumed protective immune mechanisms by challenge of 5cVAC-vaccinated mice who exhibit defects in parts of their immune system—e.g., K/O mice without functional B cells and antibodies including IgA, or by challenge infections of vaccinated CD8+ or CD4+ T cell-depleted animals.